Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Mallinckrodt
Harvard Business School
Deloitte
Fuji
Cantor Fitzgerald
Julphar
Citi

Generated: July 21, 2018

DrugPatentWatch Database Preview

Drugs in MeSH Category Angiotensin II Type 1 Receptor Blockers

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa OLMESARTAN MEDOXOMIL olmesartan medoxomil TABLET;ORAL 091079-001 Apr 24, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 077424-002 Oct 6, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Unichem Labs Ltd LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 203030-002 Oct 14, 2015 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Daiichi Sankyo BENICAR olmesartan medoxomil TABLET;ORAL 021286-003 Apr 25, 2002 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Merck
US Army
Johnson and Johnson
Julphar
Fish and Richardson
Baxter
UBS
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.